3309 Drysdale Ct
Edwardsville, IL 62025
https://seekingalpha.com/news/3392663-tg-therapeutics-backs-away-response-rate-endpoint-late-stage-study-u2-cll-accelerated
Subscribe to our email list for regular free market updates as well as a chance to get coupons!
TG Therapeutics backs away from
Posted by mercom on 25th of Sep 2018 at 09:17 am
TG Therapeutics backs away from response rate endpoint in late-stage study of U2 in CLL, accelerated approval off the table; shares down 44% premarket
https://seekingalpha.com/news/3392663-tg-therapeutics-backs-away-response-rate-endpoint-late-stage-study-u2-cll-accelerated